Chronic kidney disease (CKD) affects10% of the populationand is thethird fastest-growing cause of deathworldwide.
Its also associated with a heavy financial impact on healthcare, with its treatment costing the EU140bnper year.
It’s free, every week, in your inbox.
CKD is one of the major chronic diseases in terms of prevalence, mortality and cost.
The medtech startup will first targetend-stage patients with hyperkalemia issues and extend its scope down to earlier stage patients.
Metyos is currently at the prototype phase and is looking for participants for its clinical trials.
Story byIoanna Lykiardopoulou
Ioanna is a writer at TNW.
With a background in the humanities, she has a soft spot for social impact-enabling technologies.
Also tagged with
